A detailed history of Deutsche Bank Ag\ transactions in Alkermes Plc. stock. As of the latest transaction made, Deutsche Bank Ag\ holds 226,158 shares of ALKS stock, worth $6.51 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
226,158
Previous 203,289 11.25%
Holding current value
$6.51 Million
Previous $4.9 Million 29.21%
% of portfolio
0.0%
Previous 0.0%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$23.01 - $28.55 $526,215 - $652,909
22,869 Added 11.25%
226,158 $6.33 Million
Q2 2024

Aug 14, 2024

SELL
$23.21 - $27.24 $284,252 - $333,608
-12,247 Reduced 5.68%
203,289 $4.9 Million
Q1 2024

May 15, 2024

SELL
$26.4 - $32.56 $27,007 - $33,308
-1,023 Reduced 0.47%
215,536 $5.83 Million
Q4 2023

Feb 14, 2024

SELL
$23.37 - $28.68 $19,537 - $23,976
-836 Reduced 0.38%
216,559 $6.01 Million
Q3 2023

Nov 09, 2023

BUY
$27.17 - $31.97 $378,885 - $445,821
13,945 Added 6.85%
217,395 $6.09 Million
Q2 2023

Aug 14, 2023

SELL
$28.34 - $33.63 $1.1 Million - $1.3 Million
-38,732 Reduced 15.99%
203,450 $6.37 Million
Q1 2023

May 15, 2023

BUY
$25.31 - $29.02 $609,464 - $698,801
24,080 Added 11.04%
242,182 $6.83 Million
Q4 2022

Feb 13, 2023

BUY
$21.94 - $26.24 $307,949 - $368,304
14,036 Added 6.88%
218,102 $5.7 Million
Q3 2022

Nov 14, 2022

BUY
$22.0 - $31.87 $2.41 Million - $3.5 Million
109,698 Added 116.24%
204,066 $4.56 Million
Q2 2022

Aug 11, 2022

SELL
$26.4 - $30.54 $321,948 - $372,435
-12,195 Reduced 11.44%
94,368 $2.81 Million
Q1 2022

May 13, 2022

SELL
$23.07 - $27.99 $191,273 - $232,065
-8,291 Reduced 7.22%
106,563 $2.8 Million
Q4 2021

Feb 11, 2022

SELL
$21.47 - $32.08 $790,589 - $1.18 Million
-36,823 Reduced 24.28%
114,854 $2.67 Million
Q3 2021

Nov 04, 2021

SELL
$23.37 - $32.13 $1.36 Million - $1.87 Million
-58,267 Reduced 27.75%
151,677 $4.68 Million
Q2 2021

Aug 11, 2021

BUY
$18.78 - $25.15 $3.64 Million - $4.88 Million
194,019 Added 1218.33%
209,944 $5.15 Million
Q1 2021

May 13, 2021

SELL
$18.21 - $23.2 $35,017 - $44,613
-1,923 Reduced 10.77%
15,925 $297,000
Q4 2020

Feb 16, 2021

BUY
$15.39 - $22.1 $1,492 - $2,143
97 Added 0.55%
17,848 $356,000
Q3 2020

Nov 12, 2020

SELL
$16.16 - $20.66 $127,033 - $162,408
-7,861 Reduced 30.69%
17,751 $295,000
Q2 2020

Aug 13, 2020

SELL
$13.31 - $19.41 $6.14 Million - $8.95 Million
-461,223 Reduced 94.74%
25,612 $497,000
Q1 2020

May 14, 2020

SELL
$13.06 - $21.24 $3.24 Million - $5.27 Million
-248,345 Reduced 33.78%
486,835 $7.02 Million
Q4 2019

Feb 14, 2020

SELL
$17.29 - $21.74 $1.78 Million - $2.24 Million
-103,229 Reduced 12.31%
735,180 $15 Million
Q3 2019

Nov 14, 2019

SELL
$19.51 - $24.28 $11.2 Million - $13.9 Million
-573,521 Reduced 40.62%
838,409 $16.4 Million
Q2 2019

Aug 14, 2019

BUY
$21.47 - $37.33 $8.87 Million - $15.4 Million
413,303 Added 41.39%
1,411,930 $31.8 Million
Q1 2019

May 15, 2019

BUY
$28.4 - $36.49 $5.68 Million - $7.29 Million
199,831 Added 25.02%
998,627 $36.4 Million
Q4 2018

Feb 14, 2019

BUY
$27.94 - $44.61 $5.36 Million - $8.55 Million
191,771 Added 31.59%
798,796 $23.6 Million
Q3 2018

Dec 21, 2021

BUY
$38.6 - $46.12 $7.09 Million - $8.47 Million
183,551 Added 43.34%
607,025 $25.8 Million
Q3 2018

Nov 14, 2018

SELL
$38.6 - $46.12 $11 Million - $13.2 Million
-285,675 Reduced 40.28%
423,474 $18 Million
Q2 2018

Apr 21, 2020

BUY
$40.56 - $51.36 $3.89 Million - $4.92 Million
95,808 Added 15.62%
709,149 $29.2 Million
Q2 2018

Aug 14, 2018

BUY
$40.56 - $51.36 $4.56 Million - $5.78 Million
112,513 Added 22.47%
613,341 $25.2 Million
Q1 2018

Oct 18, 2019

BUY
$53.61 - $67.26 $9.61 Million - $12.1 Million
179,167 Added 55.7%
500,828 $29 Million
Q1 2018

May 15, 2018

BUY
$53.61 - $67.26 $2.2 Million - $2.76 Million
41,100 Added 14.65%
321,661 $18.6 Million
Q4 2017

Feb 14, 2018

SELL
$47.69 - $55.39 $3.45 Million - $4 Million
-72,295 Reduced 20.49%
280,561 $15.4 Million
Q3 2017

Nov 14, 2017

BUY
$49.16 - $54.45 $17.3 Million - $19.2 Million
352,856
352,856 $17.9 Million

Others Institutions Holding ALKS

About Alkermes plc.


  • Ticker ALKS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 164,254,000
  • Market Cap $4.73B
  • Description
  • Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...
More about ALKS
Track This Portfolio

Track Deutsche Bank Ag\ Portfolio

Follow Deutsche Bank Ag\ and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.